With every passing
day, the number of surgical procedures being performed across the world is
increasing, due to the rise in the prevalence of various diseases and
disorders. As per the World Bank, in the U.S., the surgery rate in 2012 was 30,537
per 100,000 people. Australia recorded 28,907 surgeries per 100,000
individuals, in 2015. Surgeries are sensitive procedures, as they involve the
piercing of human skin to expose internal organs, which carries a risk of
infection. Even after taking all precautions, severe surgical site infections
(SSI) are common, which is why the need to cure these as soon as possible is
growing.
The global surgical site infection market valued $4.0 billion in 2017, and it is predicted to
progress at a 6.4% CAGR during 2018–2023, to ultimately reach $5.9 billion in
2023. Apart from the increasing volume of surgeries, the prevalence of SSIs is
also surging, in high- as well as low- and middle-income countries (LMIC). The European
Centre for Disease Prevention and Control (ECDC) reported 18,364 SSI cases for
a total of 967,191 surgeries in 2013–2014. Further, as per the National Health
Surveillance Agency (ANVISA), SSIs account for almost 16% of all
hospital-acquired infections in Brazil.
 |
| To Learn More About this Report@ http://bit.ly/2woqEd8 |
Currently, North
America is the largest user of anti-SSI products, due to its huge healthcare
sector, high surgery volume, presence of leading SSI product manufacturers, well-developed
healthcare industry, and growing awareness on the topic. Within the region, the
SSI market growth in the U.S. would be faster, as the federal government
spends a considerable portion of its gross domestic product (GDP) on
healthcare. The National Health Expenditure Accounts (NHEA) reported an
increase of 4.3% in the nation’s healthcare spending during 2015–2016.
During the forecast
period, the demand for such products would see the sharpest rise in the Asia-Pacific
and Rest of the World regions, which are home to a large number of LMICs. As
per the World Health Organization (WHO), one in every 10 people undergoing
surgeries in LMICs get SSIs. Therefore, the WHO has a set of guidelines, known
as Patient Safety Solutions, which recommend doctors to keep their hands
sanitized, in order to prevent SSIs.
Therefore, as people become
more aware about SSIs, the demand for preventive and therapeutic products would
grow further.
